Variant Bernard-Soulier syndrome due to homozygous Asn45Ser mutation in the platelet glycoprotein (GP) IX in seven patients of five unrelated Finnishfamilies
S. Koskela et al., Variant Bernard-Soulier syndrome due to homozygous Asn45Ser mutation in the platelet glycoprotein (GP) IX in seven patients of five unrelated Finnishfamilies, EUR J HAEMA, 62(4), 1999, pp. 256-264
Bernard-Soulier syndrome (BSS), a rare bleeding disorder with macrothromboc
ytopenia, is caused by a defect of the platelet glycoprotein (GP) Ib/IX/V c
omplex. Here we report a variant form of BSS in eleven patients of five unr
elated families who originate from a particular area of Finland. The differ
ential diagnosis from idiopathic thrombocytopenic purpura was difficult. Bl
eeding symptoms were epistaxis and haematomas debuting in childhood, but no
spontaneous, severe bleeding episodes were reported. The platelet count va
ried from 43 to 81 x 10(9)/l. Screening the entire GP Ib alpha, GP Ib beta,
GP IX and GP V genes revealed a recurrent homozygous Asn45Ser mutation in
GP TX in all probands. Flow cytometry showed markedly reduced expression of
GP Ib (<10%), and only moderately reduced expression of GP IX (24-36%) and
GP V (35-49%). The expression of subunits seemed to vary independently fro
m the normal polymorphisms. Heterozygotes did not differ significantly from
controls by their GP Ib/IX/V expression. Since the Asn45Ser mutation has a
lso been reported in three other kindreds of northern and central European
origin, this study reveals that instead of being a mutation hot spot, it ma
y be ancient and scattered in Europe. Moderate, chronic thrombocytopenia sh
ould be carefully studied to diagnose variant BSS correctly from treatment
resistant idiopathic thrombocytopenia.